Creative Life Science Co (ROCO:7837) Short-Term Debt: NT$25 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7837 Creative Life Science Co Ltd ROCO:7837
28 GF Score
Price NT$74.50
! 3 Warning Signs
View Full Analysis

What is Creative Life Science Co Short-Term Debt?

Creative Life Science Co ROCO:7837 28 Short-Term Debt is NT$25 Mil as of Jun. 2026. GuruFocus rates ROCO:7837 with a GF Score™ of 28/100. The stock has 3 warning signs investors should review.

Creative Life Science Co's Short-Term Debt for the quarter that ended in Jun. 2026 was NT$25 Mil.

Creative Life Science Co's quarterly Short-Term Debt increased from Jun. 2025 (NT$13 Mil) to Dec. 2025 (NT$27 Mil) but then declined from Dec. 2025 (NT$27 Mil) to Jun. 2026 (NT$25 Mil).

Creative Life Science Co's annual Short-Term Debt increased from Dec. 2023 (NT$25 Mil) to Dec. 2024 (NT$68 Mil) but then declined from Dec. 2024 (NT$68 Mil) to Dec. 2025 (NT$27 Mil).

Creative Life Science Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Creative Life Science Co Short-Term Debt Related Terms

Creative Life Science Co Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Creative Life Science Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creative Life Science Co Short-Term Debt Chart

Creative Life Science Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
0.00 0.46 25.27 68.16 26.86

Creative Life Science Co Semi-Annual Data
Dec21 Dec22 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Short-Term Debt Get a 7-Day Free Trial 0.00 68.16 13.39 26.86 24.94
ROCO:7837
28GF Score
Creative Life Science Co Ltd ROCO:7837
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of NT$25 Mil mean?
Creative Life Science Co (ROCO:7837) has a Short-Term Debt of NT$25 Mil as of Jun. 2026.
Is Creative Life Science Co's Short-Term Debt too high?
Creative Life Science Co's current Short-Term Debt is NT$25 Mil. Overall, Creative Life Science Co has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Creative Life Science Co's Short-Term Debt compare to VRTX and REGN?
Creative Life Science Co's Short-Term Debt of NT$25 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Biotechnology company?
A good Short-Term Debt depends on the Biotechnology industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Creative Life Science Co's current Short-Term Debt is NT$25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creative Life Science Co stock overvalued right now?
Creative Life Science Co (ROCO:7837) has a current Short-Term Debt of NT$25 Mil. The current Short-Term Debt is NT$25 Mil. Creative Life Science Co's overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Creative Life Science Co (ROCO:7837), the current Short-Term Debt is NT$25 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Creative Life Science Co Business Description

Address Wuquan 3rd Road, No. 24, Wugu District, New Taipei City, TWN, 248021
Creative Life Science Co Ltd is engaged in providing products of microbiology, and it has prepared media products and diagnostic reagents. The main products of CMP (Creative Media Plate) are solid and liquid media, which can be used for clinical microbiology, basic microbial research, environmental monitoring, biosafety testing, and quality control. Its product line is Transport Medium, Prepared Tube Media, Prepared Plated Media, VTM & I-VTM, Bacterial strain preservation system, and CMP SteriPack triple wrapped media.
28GF Score

Get the complete analysis for ROCO:7837

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$74.50
Price